RICHARD F POPS

CIK 1126490 · Director and CEO, Alkermes plc · last filed 2026-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$67.04M

Companies

5

Total Filings

215

Lifetime Open-Market Net

-$140.30M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NBIX Director 37,798 $159.76 $6.04M -$13.18M 39 2026-05-29
ALKS Director and CEO, Alkermes plc 1,377,740 $44.28 $61.01M -$125.56M 158 2026-03-04
Epizyme, Inc. (EPZM) Delisted Director $1.47 $0 8 2020-06-02
ACCELERON PHARMA INC (XLRN) Delisted Director 32,500 $178.75 $5.81M -$1.55M 8 2019-01-29
EPIRUS Biopharmaceuticals, Inc. (CRXX) Delisted Director $0 2 2008-06-02

Recent Filings · Page 2 of 22

215 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-03-15 NBIX Mixed -$2.26M EDGAR
2024-03-12 NBIX Mixed -$175.1K EDGAR
2024-02-27 ALKS Mixed $0 EDGAR
2024-02-22 NBIX Mixed -$1.79M EDGAR
2024-02-12 ALKS Mixed +126,794 -$2.46M EDGAR
2023-05-19 NBIX Grant (A) $0 EDGAR
2023-02-24 ALKS Grant (A) $0 EDGAR
2023-02-22 ALKS Mixed +84,582 -$1.89M EDGAR
2023-01-05 NBIX Mixed -$1.60M EDGAR
2022-05-20 NBIX Grant (A) $0 EDGAR
Showing 1120 of 215
Page 2 of 22
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.